Postes actifs de Roy Duncan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Aegis Life, Inc.
 Aegis Life, Inc. BiotechnologyHealth Technology Aegis Life, Inc. is an American San Diego-based company founded in 2020 by Hong Jiang, Matthew Scholz, John Lewis, and Roy Duncan. The company develops the next generation of DNA vaccines and therapies for the world's most dangerous diseases, using the Fusogenix gene delivery platform developed by parent company Entos Pharmaceuticals. This breakthrough non-viral gene delivery platform allows Aegis Life to rapidly prototype and advance DNA medicines through the clinical trial process. John Lewis has been the CEO since 2020. | Directeur Technique/Scientifique/R&D | - | - |
| Fondateur | 01/01/2020 | - |
Historique de carrière de Roy Duncan
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aegis Life, Inc.
Aegis Life, Inc. BiotechnologyHealth Technology Aegis Life, Inc. is an American San Diego-based company founded in 2020 by Hong Jiang, Matthew Scholz, John Lewis, and Roy Duncan. The company develops the next generation of DNA vaccines and therapies for the world's most dangerous diseases, using the Fusogenix gene delivery platform developed by parent company Entos Pharmaceuticals. This breakthrough non-viral gene delivery platform allows Aegis Life to rapidly prototype and advance DNA medicines through the clinical trial process. John Lewis has been the CEO since 2020. | Health Technology |
- Bourse
- Insiders
- Roy Duncan
- Expérience
